Thus, these findings strongly support the hypothesis that a functional signaling axis consisting of HA/CD44-regulated JNK/c-Jun and miR-21 is involved in the regulation of tumor cell survival and Doxorubicin chemoresistance in breast cancer cells (Figure 3). The gene discussed is JUN; the disease is breast carcinoma.